Houston industrial biotech company Cemvita has announced two strategic moves to advance its operations in Brazil. The company, which utilizes synthetic biology to transform carbon emissions into valuable bio-based chemicals, acquired a complementary technology that expands its IP and execution of scale-up capacity, according to a news release. The acquisition will bring additional synthetic biology toolsets that Cemvita believes will assist with compressing and commercializing timelines. The ...| Energy Capital
Já o CEO da Raízen, Marcelo Mussa, vai assumir a Cosan Investimentos e terá uma posição no conselho da holding . Leia na íntegra na Forbes Brasil.| Forbes Brasil
